Corpus Engine Towards a reproducible .science file.
← All .science files

pmid:32908921

Development and Validation of the B Cell-Associated Fc Receptor-like Molecule-Based Prognostic Signature in Skin Cutaneous Melanoma.

Yu Liu · Yiding Chen · Xianyu Hu · Jialin Meng · Xiaojing Li

BioMed research international · 2020 doi:10.1155/2020/8509805

Paper

complete

Experiment

partial

Data

partial

Analysis

partial

Execution

absent

Execution evidence has not yet been added to this .science file. Explore its methods, data and open questions to plan the next step.
Record details sci_version · id · kind · revision · content_hash · schema · created_at · updated_at · generator
id
pmid:32908921
kind
science-record
content_hash
sha256:860c98f31806162b9f22aca74320c105a55a9e9658b01417f91436afc26874a2
schema
https://corpus.bntrg.co.uk/sci/1.0/sci.schema.json
created_at
2026-11-01T15:41:10Z
updated_at
2026-11-01T22:45:18Z
generator object · 2 fields
name
corpus-assay-engine
run_id
reading-sci-2026-11-01
paper object · 10 fields
state
complete
title
Development and Validation of the B Cell-Associated Fc Receptor-like Molecule-Based Prognostic Signature in Skin Cutaneous Melanoma.
doi
10.1155/2020/8509805
pmid
32908921
authors array · 5 items
[0]
Yu Liu
[1]
Yiding Chen
[2]
Xianyu Hu
[3]
Jialin Meng
[4]
Xiaojing Li
journal
BioMed research international
year
2020
abstract
METHODS: 461 patients with CM from The Cancer Genome Atlast- (TCGA-) CM cohort and 290 pateints from the GSE65904 cohort were enrolled. Student's t-test was used to compare the differences, and Pearson's correlation coefficient was employed to evaluate associations. The Kaplan-Meier (K-M) survival analysis was used to evaluate overall survival (OS). The multivariate Cox regression was conducted to generate the FCRL prognostic signature. GSEA analysis and TIMER were employed to study the potential mechanisms. RESULT: Patients with Breslow's depth high or equal to 3 cm had the lower expression of FCRL1-6 (all, P < 0.05), which indicates poor OS, as well as age, stage, and Breslow's depth subgroups (all, P < 0.001). The overall FCRL1-6 prognostic signature was generated in the TCGA cohort (K-M, P < 0.001; area under the curve (AUC), 0.649 for 3-year OS) and validated in the GSE65904 cohort (K-M, P < 0.001; AUC, 0.659 for 3-year OS). The GSEA results revealed that high expression of FCRLs indicated activated immune-associated pathways, and FCRLs are positively associated with the infiltration of B cells. CONCLUSION: Highly expressed FCRLs were observed associated with a favourable OS of CM. FCRL1-6-based prediction signature could act as a biomarker to predict the prognosis of patients with CM.
claims array · 2 items
[0] object · 6 fields
id
claim-method
statement
Student's t-test was used to compare the differences between unpaired values, while the Pearson's product-moment correlation coefficient was employed to evaluate the association between CpG sites and mRNA expression of FCRLs. The Kaplan-Meier (K-M) survival analysis of patient subgroups with high and low levels of FCRLs and clinicopathological characteristics was also performed. To evaluate the overall prognostic value of FCRLs, we generated the FCRLs prognostic signature based on the results of the multivariate Cox regression with the TCGA-CM cohort, and each patient obtained a risk score from the signature. Next, the time-dependent receiver operating characteristic (ROC) curve analysis was used to calculate the area under the curve (AUC) for 1-year, 3-year, and 5-year OS and disease-free survival, and to determine the prediction accuracy of our model using the “survivalROC” package.
kind
methodological
target
null
evidence array · 4 items
[0] object · 3 fields
asset
source:pmid:32908921
locator
sections[4] "2.2. Statistical Methods" paragraph 2
quote
Student's t-test was used to compare the differences between unpaired values, while the Pearson's product-moment correlation coefficient was employed to evaluate the association between CpG sites and mRNA expression of FCRLs.
[1] object · 3 fields
asset
source:pmid:32908921
locator
sections[4] "2.2. Statistical Methods" paragraph 2
quote
The Kaplan-Meier (K-M) survival analysis of patient subgroups with high and low levels of FCRLs and clinicopathological characteristics was also performed.
[2] object · 3 fields
asset
source:pmid:32908921
locator
sections[5] "2.3. Establishment and Validation of the Prognostic Signature" paragraph 2
quote
To evaluate the overall prognostic value of FCRLs, we generated the FCRLs prognostic signature based on the results of the multivariate Cox regression with the TCGA-CM cohort, and each patient obtained a risk score from the signature.
[3] object · 3 fields
asset
source:pmid:32908921
locator
sections[5] "2.3. Establishment and Validation of the Prognostic Signature" paragraph 2
quote
Next, the time-dependent receiver operating characteristic (ROC) curve analysis was used to calculate the area under the curve (AUC) for 1-year, 3-year, and 5-year OS and disease-free survival, and to determine the prediction accuracy of our model using the “survivalROC” package.
state
complete
[1] object · 6 fields
id
claim-data-access
statement
The data used to support the findings of this study are included within the article. The gene expression data can be accessed on The Cancer Genome Atlas (TCGA) and Gene Expression Omnibus (GEO).
kind
methodological
target
null
evidence array · 1 item
[0] object · 3 fields
asset
source:pmid:32908921
locator
sections[17] "Data Availability" paragraph 2
quote
The data used to support the findings of this study are included within the article. The gene expression data can be accessed on The Cancer Genome Atlas (TCGA) and Gene Expression Omnibus (GEO).
state
complete
gaps array · 0 items
experiment object · 8 fields
state
partial
objective
null
steps array · 3 items
[0] object · 13 fields
id
read_published_estimate
order
1
name
Read the published estimate from the source
kind
other
state
complete
blocked_on
null
description
The claim, method and evidence span published with the source article.
parameters object · 0 fields
inputs array · 1 item
[0]
source:pmid:32908921
outputs array · 1 item
[0]
the published estimate and its evidence
instruments array · 0 items
reagents array · 0 items
[1] object · 13 fields
id
obtain_source_data
order
2
name
Obtain the source data from the named repository
kind
data-preparation
state
complete
blocked_on
null
description
The GEO series accession resolves and its sample accessions are listed. This lane did not download the dataset or read its licence.
parameters object · 0 fields
inputs array · 1 item
[0]
data:geo:GSE65904
outputs array · 1 item
[0]
the source data with its repository provenance
instruments array · 0 items
reagents array · 0 items
[2] object · 13 fields
id
run_analysis
order
3
name
Run the published analysis
kind
analysis
state
blocked
blocked_on
method:student_t
description
Apply the paper's statistical method to the resolved series and compare the result with the published target.
parameters object · 0 fields
inputs array · 1 item
[0]
data:geo:GSE65904
outputs array · 1 item
[0]
the replicated result and its comparison
instruments array · 0 items
reagents array · 0 items
materials array · 0 items
instruments array · 0 items
reagents array · 0 items
conditions object · 0 fields
gaps array · 1 item
[0]
step:run_analysis blocked on method:student_t
data object · 3 fields
state
partial
assets array · 3 items
[0] object · 15 fields
id
source:pmid:32908921
role
manuscript
format
xml
media_type
application/xml
uri
https://doi.org/10.1155/2020/8509805
sha256
sha256:8c4f2c475f9860107e201a90baf4381ea86d9f4a651edf13df4db9738272e979
bytes
29737
access
open
state
resolved
reader
null
reader_status
reader_required
identifier
10.1155/2020/8509805
version
null
note
Full article fetched from PMC; the checksum covers the rendered section body, not the original XML bytes.
structure object · 4 fields
pmcid
PMC7463385
source
europe_pmc_fulltext
coverage
whole_body
text_hash_scope
rendered_section_body
[1] object · 15 fields
id
data:geo:GSE65904
role
raw
format
geo-series
media_type
application/vnd.ncbi.geo-series+json
uri
https://www.ncbi.nlm.nih.gov/geo/query/acc.cgi?acc=GSE65904
sha256
null
bytes
null
access
open
state
resolved
reader
null
reader_status
reader_required
identifier
GSE65904
version
null
note
The data used to support the findings of this study are included within the article. The gene expression data can be accessed on The Cancer Genome Atlas (TCGA) and Gene Expression Omnibus (GEO).
structure object · 15 fields
repository
GEO
access_route
GEO accession URL
access_statement_verbatim
The data used to support the findings of this study are included within the article. The gene expression data can be accessed on The Cancer Genome Atlas (TCGA) and Gene Expression Omnibus (GEO).
access_statement_kind
data_availability_statement
sample_accessions array · 214 items
[0]
GSM1608593
[1]
GSM1608594
[2]
GSM1608595
[3]
GSM1608596
[4]
GSM1608597
[5]
GSM1608598
[6]
GSM1608599
[7]
GSM1608600
[8]
GSM1608601
[9]
GSM1608602
[10]
GSM1608603
[11]
GSM1608604
[12]
GSM1608605
[13]
GSM1608606
[14]
GSM1608607
[15]
GSM1608608
[16]
GSM1608609
[17]
GSM1608610
[18]
GSM1608611
[19]
GSM1608612
[20]
GSM1608613
[21]
GSM1608614
[22]
GSM1608615
[23]
GSM1608616
[24]
GSM1608617
[25]
GSM1608618
[26]
GSM1608619
[27]
GSM1608620
[28]
GSM1608621
[29]
GSM1608622
[30]
GSM1608623
[31]
GSM1608624
[32]
GSM1608625
[33]
GSM1608626
[34]
GSM1608627
[35]
GSM1608628
[36]
GSM1608629
[37]
GSM1608630
[38]
GSM1608631
[39]
GSM1608632
[40]
GSM1608633
[41]
GSM1608634
[42]
GSM1608635
[43]
GSM1608636
[44]
GSM1608637
[45]
GSM1608638
[46]
GSM1608639
[47]
GSM1608640
[48]
GSM1608641
[49]
GSM1608642
[50]
GSM1608643
[51]
GSM1608644
[52]
GSM1608645
[53]
GSM1608646
[54]
GSM1608647
[55]
GSM1608648
[56]
GSM1608649
[57]
GSM1608650
[58]
GSM1608651
[59]
GSM1608652
[60]
GSM1608653
[61]
GSM1608654
[62]
GSM1608655
[63]
GSM1608656
[64]
GSM1608657
[65]
GSM1608658
[66]
GSM1608659
[67]
GSM1608660
[68]
GSM1608661
[69]
GSM1608662
[70]
GSM1608663
[71]
GSM1608664
[72]
GSM1608665
[73]
GSM1608666
[74]
GSM1608667
[75]
GSM1608668
[76]
GSM1608669
[77]
GSM1608670
[78]
GSM1608671
[79]
GSM1608672
[80]
GSM1608673
[81]
GSM1608674
[82]
GSM1608675
[83]
GSM1608676
[84]
GSM1608677
[85]
GSM1608678
[86]
GSM1608679
[87]
GSM1608680
[88]
GSM1608681
[89]
GSM1608682
[90]
GSM1608683
[91]
GSM1608684
[92]
GSM1608685
[93]
GSM1608686
[94]
GSM1608687
[95]
GSM1608688
[96]
GSM1608689
[97]
GSM1608690
[98]
GSM1608691
[99]
GSM1608692
[100]
GSM1608693
[101]
GSM1608694
[102]
GSM1608695
[103]
GSM1608696
[104]
GSM1608697
[105]
GSM1608698
[106]
GSM1608699
[107]
GSM1608700
[108]
GSM1608701
[109]
GSM1608702
[110]
GSM1608703
[111]
GSM1608704
[112]
GSM1608705
[113]
GSM1608706
[114]
GSM1608707
[115]
GSM1608708
[116]
GSM1608709
[117]
GSM1608710
[118]
GSM1608711
[119]
GSM1608712
[120]
GSM1608713
[121]
GSM1608714
[122]
GSM1608715
[123]
GSM1608716
[124]
GSM1608717
[125]
GSM1608718
[126]
GSM1608719
[127]
GSM1608720
[128]
GSM1608721
[129]
GSM1608722
[130]
GSM1608723
[131]
GSM1608724
[132]
GSM1608725
[133]
GSM1608726
[134]
GSM1608727
[135]
GSM1608728
[136]
GSM1608729
[137]
GSM1608730
[138]
GSM1608731
[139]
GSM1608732
[140]
GSM1608733
[141]
GSM1608734
[142]
GSM1608735
[143]
GSM1608736
[144]
GSM1608737
[145]
GSM1608738
[146]
GSM1608739
[147]
GSM1608740
[148]
GSM1608741
[149]
GSM1608742
[150]
GSM1608743
[151]
GSM1608744
[152]
GSM1608745
[153]
GSM1608746
[154]
GSM1608747
[155]
GSM1608748
[156]
GSM1608749
[157]
GSM1608750
[158]
GSM1608751
[159]
GSM1608752
[160]
GSM1608753
[161]
GSM1608754
[162]
GSM1608755
[163]
GSM1608756
[164]
GSM1608757
[165]
GSM1608758
[166]
GSM1608759
[167]
GSM1608760
[168]
GSM1608761
[169]
GSM1608762
[170]
GSM1608763
[171]
GSM1608764
[172]
GSM1608765
[173]
GSM1608766
[174]
GSM1608767
[175]
GSM1608768
[176]
GSM1608769
[177]
GSM1608770
[178]
GSM1608771
[179]
GSM1608772
[180]
GSM1608773
[181]
GSM1608774
[182]
GSM1608775
[183]
GSM1608776
[184]
GSM1608777
[185]
GSM1608778
[186]
GSM1608779
[187]
GSM1608780
[188]
GSM1608781
[189]
GSM1608782
[190]
GSM1608783
[191]
GSM1608784
[192]
GSM1608785
[193]
GSM1608786
[194]
GSM1608787
[195]
GSM1608788
[196]
GSM1608789
[197]
GSM1608790
[198]
GSM1608791
[199]
GSM1608792
[200]
GSM1608793
[201]
GSM1608794
[202]
GSM1608795
[203]
GSM1608796
[204]
GSM1608797
[205]
GSM1608798
[206]
GSM1608799
[207]
GSM1608800
[208]
GSM1608801
[209]
GSM1608802
[210]
GSM1608803
[211]
GSM1608804
[212]
GSM1608805
[213]
GSM1608806
sample_count
214
group_sizes
null
group_sizes_basis
null
platform
10558
taxon
Homo sapiens
title
Whole-genome expression analysis of melanoma tumor biopsies from a population-based cohort.
resolution_checked_at
2026-11-01T15:39:55Z
resolution_check
identifier_resolution_only_no_download_no_licence_read
downloaded
false
licence_read
false
[2] object · 16 fields
id
asset:table:pmid:32908921:1
role
table
format
jats-table
media_type
application/vnd.jats.table+json
uri
null
sha256
sha256:4eb2474f3080a48355f509cd5a7a2ab5b6ae1653f54a1df24eb45d856440f45e
bytes
1893
access
open
state
verified
reader
read_table
reader_status
available
identifier
section[12]/table-wrap[1]#tab1
version
null
note
The results of GSEA analysis in high- and low-risk groups determined by FCRLs.
structure object · 5 fields
pmcid
PMC7463385
section_index
12
section_title
3.4. GSEA Analysis to Expose the FCRL-Affected Signaling Pathways
row_count
28
column_count
4
table object · 8 fields
label
Table 1
caption
The results of GSEA analysis in high- and low-risk groups determined by FCRLs.
rows array · 28 items
[0] array · 4 items
[0]
Pathway
[1]
Size
[2]
NES
[3]
NOM P value
[1] array · 4 items
[0]
High-risk group
[1]
[2]
[3]
[2] array · 4 items
[0]
KEGG_GLYCOSYLPHOSPHATIDYLINOSITOL_GPI_ANCHOR_BIOSYNTHESIS
[1]
25
[2]
1.997
[3]
<0.001
[3] array · 4 items
[0]
KEGG_RNA_POLYMERASE
[1]
29
[2]
1.849
[3]
0.008
[4] array · 4 items
[0]
KEGG_AMINOACYL_TRNA_BIOSYNTHESIS
[1]
41
[2]
1.848
[3]
0.008
[5] array · 4 items
[0]
KEGG_GLYOXYLATE_AND_DICARBOXYLATE_METABOLISM
[1]
16
[2]
1.726
[3]
0.014
[6] array · 4 items
[0]
KEGG_VALINE_LEUCINE_AND_ISOLEUCINE_BIOSYNTHESIS
[1]
11
[2]
1.611
[3]
0.03
[7] array · 4 items
[0]
KEGG_LYSINE_DEGRADATION
[1]
44
[2]
1.526
[3]
0.05
[8] array · 4 items
[0]
Low-risk group
[1]
[2]
[3]
[9] array · 4 items
[0]
KEGG_CYTOKINE_CYTOKINE_RECEPTOR_INTERACTION
[1]
258
[2]
-2.777
[3]
<0.001
[10] array · 4 items
[0]
KEGG_CHEMOKINE_SIGNALING_PATHWAY
[1]
186
[2]
-2.765
[3]
<0.001
[11] array · 4 items
[0]
KEGG_CELL_ADHESION_MOLECULES_CAMS
[1]
131
[2]
-2.716
[3]
<0.001
[12] array · 4 items
[0]
KEGG_NATURAL_KILLER_CELL_MEDIATED_CYTOTOXICITY
[1]
130
[2]
-2.694
[3]
<0.001
[13] array · 4 items
[0]
KEGG_VIRAL_MYOCARDITIS
[1]
68
[2]
-2.647
[3]
<0.001
[14] array · 4 items
[0]
KEGG_JAK_STAT_SIGNALING_PATHWAY
[1]
151
[2]
-2.634
[3]
<0.001
[15] array · 4 items
[0]
KEGG_ANTIGEN_PROCESSING_AND_PRESENTATION
[1]
79
[2]
-2.578
[3]
<0.001
[16] array · 4 items
[0]
KEGG_LEUKOCYTE_TRANSENDOTHELIAL_MIGRATION
[1]
116
[2]
-2.565
[3]
<0.001
[17] array · 4 items
[0]
KEGG_TOLL_LIKE_RECEPTOR_SIGNALING_PATHWAY
[1]
101
[2]
-2.525
[3]
<0.001
[18] array · 4 items
[0]
KEGG_LEISHMANIA_INFECTION
[1]
69
[2]
-2.483
[3]
<0.001
[19] array · 4 items
[0]
KEGG_T_CELL_RECEPTOR_SIGNALING_PATHWAY
[1]
107
[2]
-2.478
[3]
<0.001
[20] array · 4 items
[0]
KEGG_SYSTEMIC_LUPUS_ERYTHEMATOSUS
[1]
131
[2]
-2.477
[3]
<0.001
[21] array · 4 items
[0]
KEGG_FC_GAMMA_R_MEDIATED_PHAGOCYTOSIS
[1]
95
[2]
-2.468
[3]
<0.001
[22] array · 4 items
[0]
KEGG_HEMATOPOIETIC_CELL_LINEAGE
[1]
85
[2]
-2.458
[3]
<0.001
[23] array · 4 items
[0]
KEGG_NOD_LIKE_RECEPTOR_SIGNALING_PATHWAY
[1]
61
[2]
-2.414
[3]
<0.001
[24] array · 4 items
[0]
KEGG_AUTOIMMUNE_THYROID_DISEASE
[1]
50
[2]
-2.39
[3]
<0.001
[25] array · 4 items
[0]
KEGG_APOPTOSIS
[1]
86
[2]
-2.34
[3]
<0.001
[26] array · 4 items
[0]
KEGG_B_CELL_RECEPTOR_SIGNALING_PATHWAY
[1]
74
[2]
-2.318
[3]
<0.001
[27] array · 4 items
[0]
KEGG_FC_EPSILON_RI_SIGNALING_PATHWAY
[1]
79
[2]
-2.304
[3]
<0.001
locator
section[12]/table-wrap[1]#tab1
gaps array · 2 items
[0]
asset:data:geo:GSE65904 not downloaded
[1]
asset:data:geo:GSE65904 licence not read
analysis object · 4 fields
state
partial
methods array · 4 items
[0] object · 10 fields
id
method-1
family
group_comparison
specific
student_t_test
label
Group comparison
dsl_operations array · 0 items
missing_operations array · 1 item
[0]
student_t
expressible
false
parameters object · 0 fields
data_shapes array · 1 item
[0]
two_or_more_groups_continuous
evidence object · 3 fields
score
1
band
reordered
quote
Student's t-test was used to compare the differences between unpaired values, while the Pearson's product-moment correlation coefficient was employed to evaluate the association between CpG sites and mRNA expression of FCRLs. The Kaplan-Meier (K-M) survival analysis of patient subgroups with high and low levels of FCRLs and clinicopathological characteristics was also performed. To evaluate the overall prognostic value of FCRLs, we generated the FCRLs prognostic signature based on the results of the multivariate Cox regression with the TCGA-CM cohort, and each patient obtained a risk score from the signature. Next, the time-dependent receiver operating characteristic (ROC) curve analysis was used to calculate the area under the curve (AUC) for 1-year, 3-year, and 5-year OS and disease-free survival, and to determine the prediction accuracy of our model using the “survivalROC” package.
[1] object · 10 fields
id
method-2
family
survival_analysis
specific
kaplan_meier
label
Survival analysis
dsl_operations array · 1 item
[0]
survival_km
missing_operations array · 0 items
parameters object · 0 fields
data_shapes array · 1 item
[0]
time_to_event_with_censoring
evidence object · 3 fields
score
0.7
band
medium
quote
Kaplan-Meier
[2] object · 10 fields
id
method-3
family
survival_analysis
specific
cox_proportional_hazards
label
Survival analysis
dsl_operations array · 1 item
[0]
cox_ph
missing_operations array · 0 items
parameters object · 0 fields
data_shapes array · 1 item
[0]
time_to_event_with_censoring
evidence object · 3 fields
score
0.7
band
medium
quote
Cox regression
[3] object · 10 fields
id
method-4
family
correlation_analysis
specific
pearson
label
Correlation analysis
dsl_operations array · 1 item
[0]
pearson_r
missing_operations array · 0 items
parameters object · 0 fields
data_shapes array · 1 item
[0]
paired_numeric_columns
evidence object · 3 fields
score
0.7
band
medium
quote
Pearson's correlation
targets array · 0 items
gaps array · 1 item
[0]
method.student_t
capability object · 3 fields
state
complete
requirements array · 1 item
[0] object · 6 fields
capability_id
capability:computational_analysis
label
Computational analysis platform
assay_families array · 9 items
[0]
meta_analysis
[1]
machine_learning
[2]
survival_analysis
[3]
statistical_regression
[4]
pca
[5]
molecular_docking
[6]
network_analysis
[7]
differential_expression
[8]
gwas
candidate
Automated Assays Laravel application and simulated adapters
gaps array · 0 items
readiness object · 8 fields
state
complete
tier
R1
blocked_on
nothing:replicable_now
axes object · 3 fields
method object · 5 fields
tier
R1
expressible
false
required_operations array · 0 items
missing_operations array · 1 item
[0]
student_t
basis
The paper names the method it used and the corpus's method extractor maps it onto the DSL catalogue: student_t_test.
capability object · 4 fields
tier
R1
capability_id
capability:computational_analysis
availability_state
owned
basis
The computational analysis is owned. The physical bench the paper used is not, so a physical validation cannot be run here.
data object · 6 fields
tier
R1
reachable
true
accessions array · 1 item
[0]
GSE65904
resolved_accessions array · 1 item
[0]
GSE65904
statements array · 1 item
[0]
The data used to support the findings of this study are included within the article. The gene expression data can be accessed on The Cancer Genome Atlas (TCGA) and Gene Expression Omnibus (GEO).
basis
The paper names GSE65904 in Gene Expression Omnibus (GEO) and the accession resolves in the repository. No dataset was downloaded and no licence was read.
can_run object · 3 fields
dsl_operations array · 0 items
assets array · 3 items
[0]
source:pmid:32908921
[1]
data:geo:GSE65904
[2]
asset:table:pmid:32908921:1
steps array · 0 items
must_build object · 5 fields
dsl_operations array · 1 item
[0] object · 3 fields
operation
student_t
priority
null
converters array · 0 items
readers array · 0 items
capabilities array · 0 items
data_gaps array · 1 item
[0]
data:geo:GSE65904
gaps array · 0 items
review object · 5 fields
state
partial
machine_critique object · 5 fields
kind
extraction_review
reader object · 5 fields
model
MiniMax-M3.1-Flash
provider
minimax
provider_family
minimax
read_at
2026-10-31T18:22:24Z
independence
single_reader
evidence_check object · 2 fields
method
reordered
availability
verbatim
calls
3
usage object · 3 fields
prompt_tokens
25849
completion_tokens
1556
cached_tokens
792
stages array · 1 item
[0] object · 4 fields
id
extraction
state
complete
reader
MiniMax-M3.1-Flash
provider
minimax
gaps array · 3 items
[0]
review.independent_reader
[1]
review.machine_critique
[2]
review.human_critique
execution object · 5 fields
state
absent
status
not_run
mode
null
runs array · 0 items
gaps array · 1 item
[0]
execution.not_run
provenance object · 7 fields
entities array · 3 items
[0] object · 3 fields
id
pmid:32908921
type
paper
label
pmid:32908921
[1] object · 3 fields
id
source:pmid:32908921
type
manuscript
label
PMID 32908921 full text
[2] object · 3 fields
id
data:geo:GSE65904
type
dataset
label
GEO GSE65904
activities array · 3 items
[0] object · 4 fields
id
activity-reading-sci-2026-11-01
type
classification
used array · 3 items
[0] object · 3 fields
id
pmid:32908921
type
paper
label
pmid:32908921
[1] object · 3 fields
id
source:pmid:32908921
type
manuscript
label
PMID 32908921 full text
[2] object · 3 fields
id
data:geo:GSE65904
type
dataset
label
GEO GSE65904
agent
agent:corpus-assay-engine
[1] object · 4 fields
id
activity-read-32908921
type
extraction
used array · 1 item
[0]
source:pmid:32908921
agent
agent:minimax-reader
[2] object · 4 fields
id
activity-resolve-GSE65904
type
accession_resolution
used array · 1 item
[0]
data:geo:GSE65904
agent
agent:corpus-assay-engine
agents array · 2 items
[0] object · 3 fields
id
agent:corpus-assay-engine
type
software
label
Corpus assay engine
[1] object · 3 fields
id
agent:minimax-reader
type
software
label
MiniMax literature reader
source_run_id
reading-sci-2026-11-01
dsl_catalogue_fingerprint
343fb30756ba6ec3
capability_table_fingerprint
2cb3e42f047d2ecf
snapshot_id
ba34b49490d9bfaf
lineage object · 4 fields
parent_id
pmid:32908921
parent_hash
sha256:48fdf3798716066af833596442f1ff6215ed585d5f204bfc1d7fd2f6ca9172e6
fork_of
null
gaps array · 8 items
[0]
asset:data:geo:GSE65904 licence not read
[1]
asset:data:geo:GSE65904 not downloaded
[2]
execution.not_run
[3]
method.student_t
[4]
review.human_critique
[5]
review.independent_reader
[6]
review.machine_critique
[7]
step:run_analysis blocked on method:student_t
assays array · 1 item
[0] object · 11 fields
role
analysis
definition_id
group_comparison
definition_version
f2132e96ae6c7a4e
required_operations array · 0 items
support_state
partial
source_hashes object · 1 field
dsl_catalogue
f2132e96ae6c7a4e
evidence array · 1 item
[0]
Student's t-test was used to compare the differences between unpaired values, while the Pearson's product-moment correlation coefficient was employed to evaluate the association between CpG sites and mRNA expression of FCRLs. The Kaplan-Meier (K-M) survival analysis of patient subgroups with high and low levels of FCRLs and clinicopathological characteristics was also performed. To evaluate the overall prognostic value of FCRLs, we generated the FCRLs prognostic signature based on the results of the multivariate Cox regression with the TCGA-CM cohort, and each patient obtained a risk score from the signature. Next, the time-dependent receiver operating characteristic (ROC) curve analysis was used to calculate the area under the curve (AUC) for 1-year, 3-year, and 5-year OS and disease-free survival, and to determine the prediction accuracy of our model using the “survivalROC” package.
order_basis
analysis_only
id
assay:1
Complete file
{"sci_version": "1.2", "schema": "https://corpus.bntrg.co.uk/sci/1.0/sci.schema.json", "id": "pmid:32908921", "kind": "science-record", "revision": 8, "content_hash": "sha256:860c98f31806162b9f22aca74320c105a55a9e9658b01417f91436afc26874a2", "created_at": "2026-11-01T15:41:10Z", "updated_at": "2026-11-01T22:45:18Z", "generator": {"name": "corpus-assay-engine", "run_id": "reading-sci-2026-11-01"}, "paper": {"state": "complete", "title": "Development and Validation of the B Cell-Associated Fc Receptor-like Molecule-Based Prognostic Signature in Skin Cutaneous Melanoma.", "doi": "10.1155/2020/8509805", "pmid": "32908921", "authors": ["Yu Liu", "Yiding Chen", "Xianyu Hu", "Jialin Meng", "Xiaojing Li"], "journal": "BioMed research international", "year": 2020, "abstract": "METHODS: 461 patients with CM from The Cancer Genome Atlast- (TCGA-) CM cohort and 290 pateints from the GSE65904 cohort were enrolled. Student's t-test was used to compare the differences, and Pearson's correlation coefficient was employed to evaluate associations. The Kaplan-Meier (K-M) survival analysis was used to evaluate overall survival (OS). The multivariate Cox regression was conducted to generate the FCRL prognostic signature. GSEA analysis and TIMER were employed to study the potential mechanisms.\nRESULT: Patients with Breslow's depth high or equal to 3 cm had the lower expression of FCRL1-6 (all, P < 0.05), which indicates poor OS, as well as age, stage, and Breslow's depth subgroups (all, P < 0.001). The overall FCRL1-6 prognostic signature was generated in the TCGA cohort (K-M, P < 0.001; area under the curve (AUC), 0.649 for 3-year OS) and validated in the GSE65904 cohort (K-M, P < 0.001; AUC, 0.659 for 3-year OS). The GSEA results revealed that high expression of FCRLs indicated activated immune-associated pathways, and FCRLs are positively associated with the infiltration of B cells.\nCONCLUSION: Highly expressed FCRLs were observed associated with a favourable OS of CM. FCRL1-6-based prediction signature could act as a biomarker to predict the prognosis of patients with CM.", "claims": [{"id": "claim-method", "statement": "Student's t-test was used to compare the differences between unpaired values, while the Pearson's product-moment correlation coefficient was employed to evaluate the association between CpG sites and mRNA expression of FCRLs. The Kaplan-Meier (K-M) survival analysis of patient subgroups with high and low levels of FCRLs and clinicopathological characteristics was also performed. To evaluate the overall prognostic value of FCRLs, we generated the FCRLs prognostic signature based on the results of the multivariate Cox regression with the TCGA-CM cohort, and each patient obtained a risk score from the signature. Next, the time-dependent receiver operating characteristic (ROC) curve analysis was used to calculate the area under the curve (AUC) for 1-year, 3-year, and 5-year OS and disease-free survival, and to determine the prediction accuracy of our model using the “survivalROC” package.", "kind": "methodological", "target": null, "evidence": [{"asset": "source:pmid:32908921", "locator": "sections[4] \"2.2. Statistical Methods\" paragraph 2", "quote": "Student's t-test was used to compare the differences between unpaired values, while the Pearson's product-moment correlation coefficient was employed to evaluate the association between CpG sites and mRNA expression of FCRLs."}, {"asset": "source:pmid:32908921", "locator": "sections[4] \"2.2. Statistical Methods\" paragraph 2", "quote": "The Kaplan-Meier (K-M) survival analysis of patient subgroups with high and low levels of FCRLs and clinicopathological characteristics was also performed."}, {"asset": "source:pmid:32908921", "locator": "sections[5] \"2.3. Establishment and Validation of the Prognostic Signature\" paragraph 2", "quote": "To evaluate the overall prognostic value of FCRLs, we generated the FCRLs prognostic signature based on the results of the multivariate Cox regression with the TCGA-CM cohort, and each patient obtained a risk score from the signature."}, {"asset": "source:pmid:32908921", "locator": "sections[5] \"2.3. Establishment and Validation of the Prognostic Signature\" paragraph 2", "quote": "Next, the time-dependent receiver operating characteristic (ROC) curve analysis was used to calculate the area under the curve (AUC) for 1-year, 3-year, and 5-year OS and disease-free survival, and to determine the prediction accuracy of our model using the “survivalROC” package."}], "state": "complete"}, {"id": "claim-data-access", "statement": "The data used to support the findings of this study are included within the article. The gene expression data can be accessed on The Cancer Genome Atlas (TCGA) and Gene Expression Omnibus (GEO).", "kind": "methodological", "target": null, "evidence": [{"asset": "source:pmid:32908921", "locator": "sections[17] \"Data Availability\" paragraph 2", "quote": "The data used to support the findings of this study are included within the article. The gene expression data can be accessed on The Cancer Genome Atlas (TCGA) and Gene Expression Omnibus (GEO)."}], "state": "complete"}], "gaps": []}, "experiment": {"state": "partial", "objective": null, "steps": [{"id": "read_published_estimate", "order": 1, "name": "Read the published estimate from the source", "kind": "other", "state": "complete", "blocked_on": null, "description": "The claim, method and evidence span published with the source article.", "duration_hours": null, "parameters": {}, "inputs": ["source:pmid:32908921"], "outputs": ["the published estimate and its evidence"], "instruments": [], "reagents": []}, {"id": "obtain_source_data", "order": 2, "name": "Obtain the source data from the named repository", "kind": "data-preparation", "state": "complete", "blocked_on": null, "description": "The GEO series accession resolves and its sample accessions are listed. This lane did not download the dataset or read its licence.", "duration_hours": null, "parameters": {}, "inputs": ["data:geo:GSE65904"], "outputs": ["the source data with its repository provenance"], "instruments": [], "reagents": []}, {"id": "run_analysis", "order": 3, "name": "Run the published analysis", "kind": "analysis", "state": "blocked", "blocked_on": "method:student_t", "description": "Apply the paper's statistical method to the resolved series and compare the result with the published target.", "duration_hours": null, "parameters": {}, "inputs": ["data:geo:GSE65904"], "outputs": ["the replicated result and its comparison"], "instruments": [], "reagents": []}], "materials": [], "instruments": [], "reagents": [], "conditions": {}, "gaps": ["step:run_analysis blocked on method:student_t"]}, "data": {"state": "partial", "assets": [{"id": "source:pmid:32908921", "role": "manuscript", "format": "xml", "media_type": "application/xml", "uri": "https://doi.org/10.1155/2020/8509805", "sha256": "sha256:8c4f2c475f9860107e201a90baf4381ea86d9f4a651edf13df4db9738272e979", "bytes": 29737, "access": "open", "state": "resolved", "reader": null, "reader_status": "reader_required", "identifier": "10.1155/2020/8509805", "version": null, "note": "Full article fetched from PMC; the checksum covers the rendered section body, not the original XML bytes.", "structure": {"pmcid": "PMC7463385", "source": "europe_pmc_fulltext", "coverage": "whole_body", "text_hash_scope": "rendered_section_body"}}, {"id": "data:geo:GSE65904", "role": "raw", "format": "geo-series", "media_type": "application/vnd.ncbi.geo-series+json", "uri": "https://www.ncbi.nlm.nih.gov/geo/query/acc.cgi?acc=GSE65904", "sha256": null, "bytes": null, "access": "open", "state": "resolved", "reader": null, "reader_status": "reader_required", "identifier": "GSE65904", "version": null, "note": "The data used to support the findings of this study are included within the article. The gene expression data can be accessed on The Cancer Genome Atlas (TCGA) and Gene Expression Omnibus (GEO).", "structure": {"repository": "GEO", "access_route": "GEO accession URL", "access_statement_verbatim": "The data used to support the findings of this study are included within the article. The gene expression data can be accessed on The Cancer Genome Atlas (TCGA) and Gene Expression Omnibus (GEO).", "access_statement_kind": "data_availability_statement", "sample_accessions": ["GSM1608593", "GSM1608594", "GSM1608595", "GSM1608596", "GSM1608597", "GSM1608598", "GSM1608599", "GSM1608600", "GSM1608601", "GSM1608602", "GSM1608603", "GSM1608604", "GSM1608605", "GSM1608606", "GSM1608607", "GSM1608608", "GSM1608609", "GSM1608610", "GSM1608611", "GSM1608612", "GSM1608613", "GSM1608614", "GSM1608615", "GSM1608616", "GSM1608617", "GSM1608618", "GSM1608619", "GSM1608620", "GSM1608621", "GSM1608622", "GSM1608623", "GSM1608624", "GSM1608625", "GSM1608626", "GSM1608627", "GSM1608628", "GSM1608629", "GSM1608630", "GSM1608631", "GSM1608632", "GSM1608633", "GSM1608634", "GSM1608635", "GSM1608636", "GSM1608637", "GSM1608638", "GSM1608639", "GSM1608640", "GSM1608641", "GSM1608642", "GSM1608643", "GSM1608644", "GSM1608645", "GSM1608646", "GSM1608647", "GSM1608648", "GSM1608649", "GSM1608650", "GSM1608651", "GSM1608652", "GSM1608653", "GSM1608654", "GSM1608655", "GSM1608656", "GSM1608657", "GSM1608658", "GSM1608659", "GSM1608660", "GSM1608661", "GSM1608662", "GSM1608663", "GSM1608664", "GSM1608665", "GSM1608666", "GSM1608667", "GSM1608668", "GSM1608669", "GSM1608670", "GSM1608671", "GSM1608672", "GSM1608673", "GSM1608674", "GSM1608675", "GSM1608676", "GSM1608677", "GSM1608678", "GSM1608679", "GSM1608680", "GSM1608681", "GSM1608682", "GSM1608683", "GSM1608684", "GSM1608685", "GSM1608686", "GSM1608687", "GSM1608688", "GSM1608689", "GSM1608690", "GSM1608691", "GSM1608692", "GSM1608693", "GSM1608694", "GSM1608695", "GSM1608696", "GSM1608697", "GSM1608698", "GSM1608699", "GSM1608700", "GSM1608701", "GSM1608702", "GSM1608703", "GSM1608704", "GSM1608705", "GSM1608706", "GSM1608707", "GSM1608708", "GSM1608709", "GSM1608710", "GSM1608711", "GSM1608712", "GSM1608713", "GSM1608714", "GSM1608715", "GSM1608716", "GSM1608717", "GSM1608718", "GSM1608719", "GSM1608720", "GSM1608721", "GSM1608722", "GSM1608723", "GSM1608724", "GSM1608725", "GSM1608726", "GSM1608727", "GSM1608728", "GSM1608729", "GSM1608730", "GSM1608731", "GSM1608732", "GSM1608733", "GSM1608734", "GSM1608735", "GSM1608736", "GSM1608737", "GSM1608738", "GSM1608739", "GSM1608740", "GSM1608741", "GSM1608742", "GSM1608743", "GSM1608744", "GSM1608745", "GSM1608746", "GSM1608747", "GSM1608748", "GSM1608749", "GSM1608750", "GSM1608751", "GSM1608752", "GSM1608753", "GSM1608754", "GSM1608755", "GSM1608756", "GSM1608757", "GSM1608758", "GSM1608759", "GSM1608760", "GSM1608761", "GSM1608762", "GSM1608763", "GSM1608764", "GSM1608765", "GSM1608766", "GSM1608767", "GSM1608768", "GSM1608769", "GSM1608770", "GSM1608771", "GSM1608772", "GSM1608773", "GSM1608774", "GSM1608775", "GSM1608776", "GSM1608777", "GSM1608778", "GSM1608779", "GSM1608780", "GSM1608781", "GSM1608782", "GSM1608783", "GSM1608784", "GSM1608785", "GSM1608786", "GSM1608787", "GSM1608788", "GSM1608789", "GSM1608790", "GSM1608791", "GSM1608792", "GSM1608793", "GSM1608794", "GSM1608795", "GSM1608796", "GSM1608797", "GSM1608798", "GSM1608799", "GSM1608800", "GSM1608801", "GSM1608802", "GSM1608803", "GSM1608804", "GSM1608805", "GSM1608806"], "sample_count": 214, "group_sizes": null, "group_sizes_basis": null, "platform": "10558", "taxon": "Homo sapiens", "title": "Whole-genome expression analysis of melanoma tumor biopsies from a population-based cohort.", "resolution_checked_at": "2026-11-01T15:39:55Z", "resolution_check": "identifier_resolution_only_no_download_no_licence_read", "downloaded": false, "licence_read": false}}, {"id": "asset:table:pmid:32908921:1", "role": "table", "format": "jats-table", "media_type": "application/vnd.jats.table+json", "uri": null, "sha256": "sha256:4eb2474f3080a48355f509cd5a7a2ab5b6ae1653f54a1df24eb45d856440f45e", "bytes": 1893, "access": "open", "state": "verified", "reader": "read_table", "reader_status": "available", "identifier": "section[12]/table-wrap[1]#tab1", "version": null, "note": "The results of GSEA analysis in high- and low-risk groups determined by FCRLs.", "structure": {"pmcid": "PMC7463385", "section_index": 12, "section_title": "3.4. GSEA Analysis to Expose the FCRL-Affected Signaling Pathways", "row_count": 28, "column_count": 4}, "table": {"label": "Table 1", "caption": "The results of GSEA analysis in high- and low-risk groups determined by FCRLs.", "rows": [["Pathway", "Size", "NES", "NOM P value"], ["High-risk group", "", "", ""], ["KEGG_GLYCOSYLPHOSPHATIDYLINOSITOL_GPI_ANCHOR_BIOSYNTHESIS", "25", "1.997", "<0.001"], ["KEGG_RNA_POLYMERASE", "29", "1.849", "0.008"], ["KEGG_AMINOACYL_TRNA_BIOSYNTHESIS", "41", "1.848", "0.008"], ["KEGG_GLYOXYLATE_AND_DICARBOXYLATE_METABOLISM", "16", "1.726", "0.014"], ["KEGG_VALINE_LEUCINE_AND_ISOLEUCINE_BIOSYNTHESIS", "11", "1.611", "0.03"], ["KEGG_LYSINE_DEGRADATION", "44", "1.526", "0.05"], ["Low-risk group", "", "", ""], ["KEGG_CYTOKINE_CYTOKINE_RECEPTOR_INTERACTION", "258", "-2.777", "<0.001"], ["KEGG_CHEMOKINE_SIGNALING_PATHWAY", "186", "-2.765", "<0.001"], ["KEGG_CELL_ADHESION_MOLECULES_CAMS", "131", "-2.716", "<0.001"], ["KEGG_NATURAL_KILLER_CELL_MEDIATED_CYTOTOXICITY", "130", "-2.694", "<0.001"], ["KEGG_VIRAL_MYOCARDITIS", "68", "-2.647", "<0.001"], ["KEGG_JAK_STAT_SIGNALING_PATHWAY", "151", "-2.634", "<0.001"], ["KEGG_ANTIGEN_PROCESSING_AND_PRESENTATION", "79", "-2.578", "<0.001"], ["KEGG_LEUKOCYTE_TRANSENDOTHELIAL_MIGRATION", "116", "-2.565", "<0.001"], ["KEGG_TOLL_LIKE_RECEPTOR_SIGNALING_PATHWAY", "101", "-2.525", "<0.001"], ["KEGG_LEISHMANIA_INFECTION", "69", "-2.483", "<0.001"], ["KEGG_T_CELL_RECEPTOR_SIGNALING_PATHWAY", "107", "-2.478", "<0.001"], ["KEGG_SYSTEMIC_LUPUS_ERYTHEMATOSUS", "131", "-2.477", "<0.001"], ["KEGG_FC_GAMMA_R_MEDIATED_PHAGOCYTOSIS", "95", "-2.468", "<0.001"], ["KEGG_HEMATOPOIETIC_CELL_LINEAGE", "85", "-2.458", "<0.001"], ["KEGG_NOD_LIKE_RECEPTOR_SIGNALING_PATHWAY", "61", "-2.414", "<0.001"], ["KEGG_AUTOIMMUNE_THYROID_DISEASE", "50", "-2.39", "<0.001"], ["KEGG_APOPTOSIS", "86", "-2.34", "<0.001"], ["KEGG_B_CELL_RECEPTOR_SIGNALING_PATHWAY", "74", "-2.318", "<0.001"], ["KEGG_FC_EPSILON_RI_SIGNALING_PATHWAY", "79", "-2.304", "<0.001"]], "row_count": 28, "column_count": 4, "numeric_cells": 75, "header_rows": 1, "locator": "section[12]/table-wrap[1]#tab1"}}], "gaps": ["asset:data:geo:GSE65904 not downloaded", "asset:data:geo:GSE65904 licence not read"]}, "analysis": {"state": "partial", "methods": [{"id": "method-1", "family": "group_comparison", "specific": "student_t_test", "label": "Group comparison", "dsl_operations": [], "missing_operations": ["student_t"], "expressible": false, "parameters": {}, "data_shapes": ["two_or_more_groups_continuous"], "evidence": {"score": 1.0, "band": "reordered", "quote": "Student's t-test was used to compare the differences between unpaired values, while the Pearson's product-moment correlation coefficient was employed to evaluate the association between CpG sites and mRNA expression of FCRLs. The Kaplan-Meier (K-M) survival analysis of patient subgroups with high and low levels of FCRLs and clinicopathological characteristics was also performed. To evaluate the overall prognostic value of FCRLs, we generated the FCRLs prognostic signature based on the results of the multivariate Cox regression with the TCGA-CM cohort, and each patient obtained a risk score from the signature. Next, the time-dependent receiver operating characteristic (ROC) curve analysis was used to calculate the area under the curve (AUC) for 1-year, 3-year, and 5-year OS and disease-free survival, and to determine the prediction accuracy of our model using the “survivalROC” package."}}, {"id": "method-2", "family": "survival_analysis", "specific": "kaplan_meier", "label": "Survival analysis", "dsl_operations": ["survival_km"], "missing_operations": [], "expressible": true, "parameters": {}, "data_shapes": ["time_to_event_with_censoring"], "evidence": {"score": 0.7, "band": "medium", "quote": "Kaplan-Meier"}}, {"id": "method-3", "family": "survival_analysis", "specific": "cox_proportional_hazards", "label": "Survival analysis", "dsl_operations": ["cox_ph"], "missing_operations": [], "expressible": true, "parameters": {}, "data_shapes": ["time_to_event_with_censoring"], "evidence": {"score": 0.7, "band": "medium", "quote": "Cox regression"}}, {"id": "method-4", "family": "correlation_analysis", "specific": "pearson", "label": "Correlation analysis", "dsl_operations": ["pearson_r"], "missing_operations": [], "expressible": true, "parameters": {}, "data_shapes": ["paired_numeric_columns"], "evidence": {"score": 0.7, "band": "medium", "quote": "Pearson's correlation"}}], "targets": [], "gaps": ["method.student_t"]}, "capability": {"state": "complete", "requirements": [{"capability_id": "capability:computational_analysis", "label": "Computational analysis platform", "assay_families": ["meta_analysis", "machine_learning", "survival_analysis", "statistical_regression", "pca", "molecular_docking", "network_analysis", "differential_expression", "gwas"], "availability_state": "owned", "tier_unlocked": "R1", "candidate": "Automated Assays Laravel application and simulated adapters"}], "gaps": []}, "readiness": {"state": "complete", "tier": "R1", "blocking_axis": "none", "blocked_on": "nothing:replicable_now", "axes": {"method": {"tier": "R1", "expressible": false, "required_operations": [], "missing_operations": ["student_t"], "basis": "The paper names the method it used and the corpus's method extractor maps it onto the DSL catalogue: student_t_test."}, "capability": {"tier": "R1", "capability_id": "capability:computational_analysis", "availability_state": "owned", "basis": "The computational analysis is owned. The physical bench the paper used is not, so a physical validation cannot be run here."}, "data": {"tier": "R1", "reachable": true, "accessions": ["GSE65904"], "resolved_accessions": ["GSE65904"], "statements": ["The data used to support the findings of this study are included within the article. The gene expression data can be accessed on The Cancer Genome Atlas (TCGA) and Gene Expression Omnibus (GEO)."], "basis": "The paper names GSE65904 in Gene Expression Omnibus (GEO) and the accession resolves in the repository. No dataset was downloaded and no licence was read."}}, "can_run": {"dsl_operations": [], "assets": ["source:pmid:32908921", "data:geo:GSE65904", "asset:table:pmid:32908921:1"], "steps": []}, "must_build": {"dsl_operations": [{"operation": "student_t", "unlocks_papers": null, "priority": null}], "converters": [], "readers": [], "capabilities": [], "data_gaps": ["data:geo:GSE65904"]}, "gaps": []}, "review": {"state": "partial", "machine_critique": {"kind": "extraction_review", "reader": {"model": "MiniMax-M3.1-Flash", "provider": "minimax", "provider_family": "minimax", "read_at": "2026-10-31T18:22:24Z", "independence": "single_reader"}, "evidence_check": {"method": "reordered", "availability": "verbatim"}, "calls": 3, "usage": {"prompt_tokens": 25849, "completion_tokens": 1556, "cached_tokens": 792}}, "human_critique": null, "stages": [{"id": "extraction", "state": "complete", "reader": "MiniMax-M3.1-Flash", "provider": "minimax"}], "gaps": ["review.independent_reader", "review.machine_critique", "review.human_critique"]}, "execution": {"state": "absent", "status": "not_run", "mode": null, "runs": [], "gaps": ["execution.not_run"]}, "provenance": {"entities": [{"id": "pmid:32908921", "type": "paper", "label": "pmid:32908921"}, {"id": "source:pmid:32908921", "type": "manuscript", "label": "PMID 32908921 full text"}, {"id": "data:geo:GSE65904", "type": "dataset", "label": "GEO GSE65904"}], "activities": [{"id": "activity-reading-sci-2026-11-01", "type": "classification", "used": [{"id": "pmid:32908921", "type": "paper", "label": "pmid:32908921"}, {"id": "source:pmid:32908921", "type": "manuscript", "label": "PMID 32908921 full text"}, {"id": "data:geo:GSE65904", "type": "dataset", "label": "GEO GSE65904"}], "agent": "agent:corpus-assay-engine"}, {"id": "activity-read-32908921", "type": "extraction", "used": ["source:pmid:32908921"], "agent": "agent:minimax-reader"}, {"id": "activity-resolve-GSE65904", "type": "accession_resolution", "used": ["data:geo:GSE65904"], "agent": "agent:corpus-assay-engine"}], "agents": [{"id": "agent:corpus-assay-engine", "type": "software", "label": "Corpus assay engine"}, {"id": "agent:minimax-reader", "type": "software", "label": "MiniMax literature reader"}], "source_run_id": "reading-sci-2026-11-01", "dsl_catalogue_fingerprint": "343fb30756ba6ec3", "capability_table_fingerprint": "2cb3e42f047d2ecf", "snapshot_id": "ba34b49490d9bfaf"}, "lineage": {"parent_id": "pmid:32908921", "parent_hash": "sha256:48fdf3798716066af833596442f1ff6215ed585d5f204bfc1d7fd2f6ca9172e6", "fork_of": null, "generation": 7}, "gaps": ["asset:data:geo:GSE65904 licence not read", "asset:data:geo:GSE65904 not downloaded", "execution.not_run", "method.student_t", "review.human_critique", "review.independent_reader", "review.machine_critique", "step:run_analysis blocked on method:student_t"], "assays": [{"role": "analysis", "definition_id": "group_comparison", "definition_version": "f2132e96ae6c7a4e", "definition_digest": null, "required_operations": [], "support_state": "partial", "source_hashes": {"dsl_catalogue": "f2132e96ae6c7a4e"}, "confidence": 1.0, "evidence": ["Student's t-test was used to compare the differences between unpaired values, while the Pearson's product-moment correlation coefficient was employed to evaluate the association between CpG sites and mRNA expression of FCRLs. The Kaplan-Meier (K-M) survival analysis of patient subgroups with high and low levels of FCRLs and clinicopathological characteristics was also performed. To evaluate the overall prognostic value of FCRLs, we generated the FCRLs prognostic signature based on the results of the multivariate Cox regression with the TCGA-CM cohort, and each patient obtained a risk score from the signature. Next, the time-dependent receiver operating characteristic (ROC) curve analysis was used to calculate the area under the curve (AUC) for 1-year, 3-year, and 5-year OS and disease-free survival, and to determine the prediction accuracy of our model using the “survivalROC” package."], "order_basis": "analysis_only", "id": "assay:1"}]}